Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury.

PURPOSE To assess the utility of dosimetric/functional metrics as predictors of symptomatic radiation pneumonitis using receiver operating characteristic curves. METHODS Between 1991 and 1999, 277 patients were enrolled on a prospective clinical study to relate radiation therapy (RT) induced changes in lung function with dosimetric and functional metrics. Pre-RT whole and regional functional assessments included pulmonary function tests and single photon emission computed tomography lung perfusion scans. Patients had three-dimensional planning scans and dose calculations (reflecting tissue density heterogeneity) to provide a dose-volume histogram of the lung and associated dosimetric parameters (MLD = mean lung dose, V30 = % of lung receiving >or=30 Gy). Fusion of single photon emission computed tomography and computed tomography scans provides perfusion-weighted dose-function histograms and associated dosimetric parameters (mean perfusion-weighted lung dose). The incidence of clinically relevant radiation pneumonitis requiring steroids was related to the dosimetric and functional metrics. The predictive abilities of models (sensitivity and specificity) were calculated and compared based on the area beneath receiver operating characteristic (ROC) curves (Wilcoxon rank-sum and chi-square). RESULTS Twenty-seven of 162 evaluable patients with >or=6 months' follow-up developed pneumonitis requiring steroids. Single metrics were typically not good predictors for pneumonitis ( area under ROC curve = 0.5-0.68). The two-dimensional models (e.g., MLD and pre-RT diffusion capacity for carbon monoxide) generally provided greater ROC areas (0.61-0.72). Overall, the models that considered a measure of pre-RT lung function (i.e., pulmonary function tests), the MLD, and mean perfusion-weighted lung dose were best correlated with outcome (ROC area: 0.7) (p < 0.05 compared to unidimensional models). However, because the area under the ROC curve for these models was <<1, they too seemed not to be ideal. CONCLUSION Predicting symptomatic radiation pneumonitis remains difficult. Multiparameter models that consider pre-RT pulmonary function and the three-dimensional dose distribution seem to be best able to predict outcome. Additional studies are needed to better understand the dosimetric/functional determinants of radiation pneumonitis.

[1]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[2]  R. Clough,et al.  Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. , 2001, International journal of radiation oncology, biology, physics.

[3]  M T Munley,et al.  Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. , 2001, International journal of radiation oncology, biology, physics.

[4]  R. Komaki,et al.  Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. , 1998, International journal of radiation oncology, biology, physics.

[5]  G J Kutcher,et al.  Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  S. Kesten,et al.  Variability in performance of timed walk tests in pulmonary rehabilitation programs. , 2000, Chest.

[7]  R. Jaszczak,et al.  The role of lung perfusion imaging in predicting the direction of radiation‐induced changes in pulmonary function tests , 2000, Cancer.

[8]  S. Spencer,et al.  Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: analysis of early and late pulmonary morbidity. , 1999, Seminars in radiation oncology.

[9]  R W de Boer,et al.  Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  L. Boersma,et al.  Recovery of overall and local lung function loss 18 months after irradiation for malignant lymphoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  C. Metz ROC Methodology in Radiologic Imaging , 1986, Investigative radiology.

[12]  M. Fujita,et al.  Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. , 2000, American journal of respiratory and critical care medicine.

[13]  D J Vining,et al.  Receiver operating characteristic curves: a basic understanding. , 1992, Radiographics : a review publication of the Radiological Society of North America, Inc.

[14]  R. Jaszczak,et al.  Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction? , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  R. Jaszczak,et al.  The effect of patient-specific factors on radiation-induced regional lung injury. , 1999, International journal of radiation oncology, biology, physics.

[16]  R. Henriksson,et al.  Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  M. Greiner,et al.  Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. , 2000, Preventive veterinary medicine.

[18]  J A Purdy,et al.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.

[19]  T. J. Robnett,et al.  Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. , 2000, International journal of radiation oncology, biology, physics.

[20]  R K Ten Haken,et al.  Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. , 1998, International journal of radiation oncology, biology, physics.

[21]  R K Ten Haken,et al.  Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. , 1994, International journal of radiation oncology, biology, physics.

[22]  C. Metz Basic principles of ROC analysis. , 1978, Seminars in nuclear medicine.

[23]  M T Munley,et al.  Physical and biological predictors of changes in whole-lung function following thoracic irradiation. , 1997, International journal of radiation oncology, biology, physics.

[24]  K Hirata,et al.  Risk factors of pneumonitis following chemoradiotherapy for lung cancer. , 1998, European journal of cancer.

[25]  P Schraube,et al.  Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. , 1995, International journal of radiation oncology, biology, physics.